Table 3.
Cox regression analyses of PD1 and PDL1 gene expression levels at late stage lung cancer patients.
Adenocarcinoma | Squamous Cell Carcinoma | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Relapse | Relapse | ||||||||||||
No | Yes | No | Yes | ||||||||||
Number (%) | Number (%) | P-value a | HR (95% CI) b | P-value | Number (%) | Number (%) | P-value a | HR (95% CI) b | P-value | ||||
Univariate | Univariate | ||||||||||||
PD1 <= 0.82 | 28 (56.00) | 22 (44.00) | 0.2276 | Ref. | PD1 <= 1.17 | 25 (54.35) | 21 (45.65) | 0.0318 | Ref. | ||||
PD1 > 0.82 | 43 (45.26) | 52 (54.74) | 1.27 (0.75 ~ 2.14) | 0.3739 | PD1 > 1.17 | 8 (27.59) | 21 (72.41) | 2.08 (1.07 ~ 4.04) | 0.0302 | ||||
PDL1 <= 1.23 | 57 (51.82) | 53 (48.18) | 0.2487 | Ref. | PDL1 <= 1.36 | 25 (56.82) | 19 (43.18) | 0.0098 | Ref. | ||||
PDL1 > 1.23 | 14 (40.00) | 21 (60.00) | 1.13 (0.65 ~ 1.96) | 0.6772 | PDL1 > 1.36 | 8 (25.81) | 23 (74.19) | 2.39 (1.21 ~ 4.69) | 0.0118 | ||||
Additive model c | 1.16 (0.83 ~ 1.63) | 0.3932 | Additive model c | 1.51 (1.07 ~ 2.11) | 0.0176 | ||||||||
Number of higher expression PD1/PDL1 | Number of higher expression PD1/PDL1 | ||||||||||||
0 higher expression gene | 25 (53.19) | 22 (46.81) | 0.1723 | Ref. | 0 higher expression gene | 25 (56.82) | 19 (43.18) | 0.0152 | Ref. | ||||
1 higher expression gene | 35 (53.03) | 31 (46.97) | 0.97 (0.55 ~ 1.71) | 0.9174 | 1 higher expression gene | 0 (0.00) | 2 (100.00) | 3.73 (0.83 ~ 16.84) | 0.0865 | ||||
2 higher expression gene | 11 (34.38) | 21 (65.63) | 1.37 (0.71 ~ 2.65) | 0.3548 | 2 higher expression gene | 8 (27.59) | 21 (72.41) | 2.31 (1.16 ~ 4.60) | 0.0170 | ||||
Outcomes | Outcomes | ||||||||||||
Alive | Dead | Alive | Dead | ||||||||||
Number (%) | Number (%) | P-value a | HR (95% CI) b | P-value | Number (%) | Number (%) | P-value a | HR (95% CI) b | P-value | ||||
Univariate | Univariate | ||||||||||||
PD1 <= 0.82 | 29 (47.54) | 32 (52.46) | 0.8725 | Ref. | PD1 <= 1.17 | 26 (43.33) | 34 (56.67) | 0.0002 | Ref. | ||||
PD1 > 0.82 | 47 (46.08) | 55 (53.92) | 0.89 (0.57 ~ 1.40) | 0.6177 | PD1 > 1.17 | 2 (6.45) | 29 (93.55) | 1.87 (1.10 ~ 3.18) | 0.0216 | ||||
PDL1 <= 1.23 | 62 (48.82) | 65 (51.18) | 0.3459 | Ref. | PDL1 <= 1.36 | 26 (44.83) | 32 (55.17) | 0.0001 | Ref. | ||||
PDL1 > 1.23 | 14 (38.89) | 22 (61.11) | 0.90 (0.53 ~ 1.51) | 0.6829 | PDL1 > 1.36 | 2 (6.06) | 31 (93.94) | 2.07 (1.21 ~ 3.53) | 0.0079 | ||||
Additive model c | 0.92 (0.68 ~ 1.24) | 0.5681 | Additive model c | 1.41 (1.08 ~ 1.84) | 0.0127 | ||||||||
Number of higher expression PD1/PDL1 | Number of higher expression PD1/PDL1 | ||||||||||||
0 higher expression gene | 27 (46.55) | 31 (53.45) | 0.3607 | Ref. | 0 higher expression gene | 26 (44.83) | 32 (55.17) | 0.0001 | Ref. | ||||
1 higher expression gene | 37 (51.39) | 35 (48.61) | 0.82 (0.51 ~ 1.35) | 0.4395 | 1 higher expression gene | 0 (0.00) | 2 (100.00) | 4.68 (1.07 ~ 20.38) | 0.0400 | ||||
2 higher expression gene | 12 (36.36) | 21 (63.64) | 0.86 (0.48 ~ 1.57) | 0.6321 | 2 higher expression gene | 2 (6.45) | 29 (93.55) | 2.00 (1.16 ~ 3.44) | 0.0126 |
HR, Hazard ratio; CI, confidence interval; Ref., reference group.
P-value for Fisher exact test.
Adjusted for age and gender.
Trend test for additive model.
Bold face: statistically significant (P value<0.05).